Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2011

Open Access 01-12-2011 | Case report

Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report

Authors: Yusaku Shirai, Hitoshi Yoshiji, Saiho Ko, Masaharu Yamazaki, Yasuhide Ikenaka, Ryuichi Noguchi, Chie Morioka, Kosuke Kaji, Yosuke Aihara, Keisuke Nakanishi, Junichi Yamao, Masahisa Toyohara, Akira Mitoro, Masayoshi Sawai, Motoyuki Yoshida, Masao Fujimoto, Masahito Uemura, Yoshiyuki Nakajima, Hiroshi Fukui

Published in: Journal of Medical Case Reports | Issue 1/2011

Login to get access

Abstract

Introduction

Budd-Chiari syndrome is a very rare pathological entity that ultimately leads to liver failure. Several therapeutic modalities, including percutaneous transluminal angioplasty, have been attempted to save the life of patients with Budd-Chiari syndrome. Few reports have described a salvage living donor liver transplantation performed after percutaneous transluminal angioplasty in a patient with acute Budd-Chiari syndrome.

Case presentation

A 26-year-old Japanese man developed severe progressive manifestations, such as massive ascites and hematemesis due to rupture of esophageal varices. After making several investigations, we diagnosed the case as Budd-Chiari syndrome. We first performed percutaneous transluminal angioplasty to dilate a short-segment stenosis of his inferior vena cava. The first percutaneous transluminal angioplasty greatly improved the clinical manifestations. However, after a year, re-stenosis was detected, and a second percutaneous transluminal angioplasty failed to open the severe stricture of his inferior vena cava. Since our patient had manifestations of acute liver failure, we decided to perform salvage living donor liver transplantation from his brother. The transplantation was successfully performed and all clinical manifestations were remarkably alleviated.

Conclusion

In cases of recurrent Budd-Chiari syndrome, the blocked hepatic venous outflow is not always relieved, even with invasive therapies. We have to take into account the possibility of adopting alternative salvage therapies if the first therapeutic modalities fail. When invasive therapy such as percutaneous transluminal angioplasty fails, liver transplantation should be considered as an alternative option.
Appendix
Available only for authorised users
Literature
1.
go back to reference Valla DC: Primary Budd-Chiari syndrome. J Hepatol. 2009, 50 (1): 195-203. 10.1016/j.jhep.2008.10.007.CrossRefPubMed Valla DC: Primary Budd-Chiari syndrome. J Hepatol. 2009, 50 (1): 195-203. 10.1016/j.jhep.2008.10.007.CrossRefPubMed
2.
go back to reference Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL, EN-Vie (European Network for Vascular Disorders of the Liver): Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009, 151 (3): 167-175.CrossRefPubMed Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL, EN-Vie (European Network for Vascular Disorders of the Liver): Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009, 151 (3): 167-175.CrossRefPubMed
3.
go back to reference Horton JD, San Miguel FL, Membreno F, Wright F, Paima J, Foster P, Ortiz JA: Budd-Chiari syndrome: illustrated review of current management. Liver Int. 2008, 28 (4): 455-466. 10.1111/j.1478-3231.2008.01684.x.CrossRefPubMed Horton JD, San Miguel FL, Membreno F, Wright F, Paima J, Foster P, Ortiz JA: Budd-Chiari syndrome: illustrated review of current management. Liver Int. 2008, 28 (4): 455-466. 10.1111/j.1478-3231.2008.01684.x.CrossRefPubMed
4.
go back to reference Menon KV, Shah V, Kamath PS: The Budd-Chiari syndrome. N Engl J Med. 2004, 350 (6): 578-585. 10.1056/NEJMra020282.CrossRefPubMed Menon KV, Shah V, Kamath PS: The Budd-Chiari syndrome. N Engl J Med. 2004, 350 (6): 578-585. 10.1056/NEJMra020282.CrossRefPubMed
5.
go back to reference Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, Okudaira M, Ohbu M, Okuda K: Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol. 1995, 22 (1): 1-9. 10.1016/0168-8278(95)80252-5.CrossRefPubMed Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, Okudaira M, Ohbu M, Okuda K: Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol. 1995, 22 (1): 1-9. 10.1016/0168-8278(95)80252-5.CrossRefPubMed
6.
go back to reference Shrestha S: Bacterial peritonitis in hepatic inferior vena cava disease: a hypothesis to explain the cause of infection in high protein ascites. Hepatol Res. 2002, 24 (1): 42-10.1016/S1386-6346(02)00018-9.CrossRefPubMed Shrestha S: Bacterial peritonitis in hepatic inferior vena cava disease: a hypothesis to explain the cause of infection in high protein ascites. Hepatol Res. 2002, 24 (1): 42-10.1016/S1386-6346(02)00018-9.CrossRefPubMed
7.
go back to reference Valla DC: The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology. 2003, 38 (4): 793-803.CrossRefPubMed Valla DC: The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology. 2003, 38 (4): 793-803.CrossRefPubMed
8.
go back to reference Shirai Y, Yoshiji H, Fujimoto M, Kojima H, Yanase K, Namisaki T, Kitade M, Yamamoto K, Sakaguchi H, Kichikawa K, Fukui H: Successful treatment of acute Budd-Chiari syndrome with percutaneous transluminal angioplasty. Abdom Imaging. 2004, 29 (6): 685-687. 10.1007/s00261-004-0183-6.CrossRefPubMed Shirai Y, Yoshiji H, Fujimoto M, Kojima H, Yanase K, Namisaki T, Kitade M, Yamamoto K, Sakaguchi H, Kichikawa K, Fukui H: Successful treatment of acute Budd-Chiari syndrome with percutaneous transluminal angioplasty. Abdom Imaging. 2004, 29 (6): 685-687. 10.1007/s00261-004-0183-6.CrossRefPubMed
9.
go back to reference Yamada T, Tanaka K, Ogura Y, Ko S, Nakajima Y, Takada Y, Uemoto S: Surgical techniques and long-term outcomes of living donor liver transplantation for Budd-Chiari syndrome. Am J Transplant. 2006, 6 (10): 2463-2469. 10.1111/j.1600-6143.2006.01505.x.CrossRefPubMed Yamada T, Tanaka K, Ogura Y, Ko S, Nakajima Y, Takada Y, Uemoto S: Surgical techniques and long-term outcomes of living donor liver transplantation for Budd-Chiari syndrome. Am J Transplant. 2006, 6 (10): 2463-2469. 10.1111/j.1600-6143.2006.01505.x.CrossRefPubMed
10.
go back to reference Washburn WK, Gish RG, Kamath PS: Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome. Liver Transpl. 2006, 12 (12 Suppl 3): S93-94. 10.1002/lt.20964.CrossRefPubMed Washburn WK, Gish RG, Kamath PS: Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome. Liver Transpl. 2006, 12 (12 Suppl 3): S93-94. 10.1002/lt.20964.CrossRefPubMed
Metadata
Title
Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report
Authors
Yusaku Shirai
Hitoshi Yoshiji
Saiho Ko
Masaharu Yamazaki
Yasuhide Ikenaka
Ryuichi Noguchi
Chie Morioka
Kosuke Kaji
Yosuke Aihara
Keisuke Nakanishi
Junichi Yamao
Masahisa Toyohara
Akira Mitoro
Masayoshi Sawai
Motoyuki Yoshida
Masao Fujimoto
Masahito Uemura
Yoshiyuki Nakajima
Hiroshi Fukui
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2011
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-5-124

Other articles of this Issue 1/2011

Journal of Medical Case Reports 1/2011 Go to the issue